Aducanumab is a monoclonal antibody that has been shown to reduce amyloid plaques in the brain, which are a hallmark of Alzheimer's disease. In clinical trials, Aducanumab has been shown to slow the progression of cognitive decline in patients with Alzheimer's disease.

The Inflation Reduction Act is a law that was passed in the United States in 2022. It includes a number of provisions to lower the cost of prescription drugs, including allowing Medicare to negotiate drug prices, capping out-of-pocket costs for Medicare Part D beneficiaries, and providing subsidies for people who buy health insurance through the Affordable Care Act.

The Access to Medicines Initiative is a global initiative that was launched by the World Health Organization in 2006. It aims to improve access to essential medicines for people in developing countries. The initiative focuses on a number of areas, including research and development, manufacturing, distribution, and pricing.

The Kaiser Family Foundation's Health Care Cost and Utilization Project is a non-profit organization that conducts research on health care costs and utilization. In its 2023 report, the project found that the cost of cancer care in the United States is rising faster than the rate of inflation. The report also found that the cost of cancer care varies widely across different types of cancer and different geographic areas.

The Commonwealth Fund's Mirror, Mirror on the Wall: An International Update on the Comparative Performance of American Health Care 2023 is a report that compares the health care systems of 11 high-income countries. The report found that the United States has the highest health care spending per capita, but it also has the worst health outcomes among the countries studied. The report also found that the United States has a high rate of preventable deaths and a high rate of chronic diseases.